TC BioPharm announced that the company has regained compliance with the Nasdaq Stock Market Listing Rule 5550(b) which will maintain the listing of the company’s American depositary shares on the Nasdaq Global Select Market.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>